NCT01676922已完成不适用
Prospective Non-interventional Study to Collect Data on the Use of Avastin and Conventional Chemotherapy for the Treatment of Previously Untreated Metastatic Colorectal Cancer in Patients >/= 70 Years
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 256
- 主要终点
- Treatment duration in patients receiving chemotherapy with Avastin as first-line therapy in daily clinical practice
研究概览
简要总结
This observational study will evaluate the use of Avastin (bevacizumab) and conventional chemotherapy in patients >/= 70 years of age with previously untreated metastatic colorectal cancer. Data will be collected from each patient from initiation of treatment until disease progression occurs (minimum follow-up 12 months).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 70 Years 至 —（Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, >/ 70 years of age
- •Previously untreated metastatic colorectal cancer
- •Patient considered suitable to receive chemotherapy with or without Avastin
排除标准
- •Participation in any other clinical trial or study with the exception of participation in registries
结局指标
主要结局
Treatment duration in patients receiving chemotherapy with Avastin as first-line therapy in daily clinical practice
时间窗: approximately 24 months
次要结局
- Treatment duration in patients receiving chemotherapy alone as first-line therapy in daily clinical practice(approximately 24 months)
- Safety: Incidence of adverse events/adverse events of special interest(approximately 24 months)
- Clinical/demographic patient characteristics at baseline(approximately 24 months)
- Dosage/regimen(approximately 24 months)
- Correlation between Comprehensive Geriatric Assessment (CGA) scores and initial treatment(approximately 24 months)
研究者
相似试验
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast CancerBreast CancerNCT01661153Hoffmann-La Roche16
已完成
不适用
A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical CancerCervical CancerNCT03071848Hoffmann-La Roche84
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT)Colorectal CancerNCT01697449Hoffmann-La Roche191
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in Combination With Interferon Alpha-2a as First-Line Treatment in Patients With Advanced and/or Metastatic Renal Cell CarcinomaRenal Cell CancerNCT01351571Hoffmann-La Roche5
已完成
不适用
An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)Colorectal CancerNCT01674907Hoffmann-La Roche27